menu
    • menu

    Company profile for Medicenna Therapeutics

    NEW Drugs in Dev: 6
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medicenna is a clinical stage immunooncology company advancing novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines™ and first in class Empowered Cytokines™. We are developing a unique set of tunable Superkines™ that can be fused with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment and cancer stem cells without harming he...
    Medicenna is a clinical stage immunooncology company advancing novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines™ and first in class Empowered Cytokines™. We are developing a unique set of tunable Superkines™ that can be fused with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment and cancer stem cells without harming healthy cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Medicenna TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1920 Yonge St Toronto, Ontario, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medicenna.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/medicenna-therapeutics-corp.
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/medicenna1?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Bio-Europe Spring

    Bio-Europe Spring

    Not Confirmed

    envelop Contact Supplier

    Bio-Europe Spring

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medicenna To Present Anti-PD-1 IL-2 Superkine Data At AACR 2026
    Medicenna To Present Anti-PD-1 IL-2 Superkine Data At AACR 2026

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258064/0/en/Medicenna-to-Present-Preclinical-Data-from-its-First-in-Class-Tumor-Anchored-and-Conditionally-Activated-Anti-PD-1-IL-2-Bifunctional-Superkine-at-the-AACR-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Medicenna Therapeutics To Participate In Future Conferences
    Medicenna Therapeutics To Participate In Future Conferences

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240097/0/en/Medicenna-Therapeutics-Announces-Participation-in-Upcoming-Conferences.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    Medicenna Announces Changes To Board Composition
    Medicenna Announces Changes To Board Composition

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/13/3238008/0/en/Medicenna-Announces-Changes-to-Board-Composition.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    Medicenna Therapeutics Reveals Q3 Fiscal 2026 Financials
    Medicenna Therapeutics Reveals Q3 Fiscal 2026 Financials

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/13/3238090/0/en/Medicenna-Therapeutics-Reports-Third-Quarter-Fiscal-2026-Financial-Results-and-Provides-a-Corporate-Update.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    Medicenna Therapeutics Reveals Program Updates And 2026 Outlook
    Medicenna Therapeutics Reveals Program Updates And 2026 Outlook

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219431/0/en/Medicenna-Therapeutics-Announces-Key-Program-Updates-and-2026-Outlook.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share
    Medicenna Enhances MDNA11 Trial Results At ESMO-IO Congress
    Medicenna Enhances MDNA11 Trial Results At ESMO-IO Congress

    10 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/10/3203073/0/en/Medicenna-Updates-MDNA11-Clinical-Trial-Results-at-the-ESMO-IO-Congress-2025-Further-Bolstering-its-Anti-Tumor-Activity-in-Advanced-Solid-Tumors.html

    GLOBENEWSWIRE
    10 Dec 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search